|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Wang-Gillam A, Li CP, Bodoky G, Dean A,
Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, et
al NAPOLI-1 Study Group: Nanoliposomal irinotecan with fluorouracil
and folinic acid in metastatic pancreatic cancer after previous
gemcitabine-based therapy (NAPOLI-1): A global, randomised,
open-label, phase 3 trial. Lancet. 387:545–557. 2016. View Article : Google Scholar
|
|
3
|
Deplanque G and Demartines N: Pancreatic
cancer: Are more chemotherapy and surgery needed. Lancet.
389:985–986. 2017. View Article : Google Scholar
|
|
4
|
Kamisawa T, Isawa T, Koike M, Tsuruta K
and Okamoto A: Hematogenous metastases of pancreatic ductal
carcinoma. Pancreas. 11:345–349. 1995. View Article : Google Scholar
|
|
5
|
Sossey-Alaoui K: Surfing the big WAVE:
Insights into the role of WAVE3 as a driving force in cancer
progression and metastasis. Semin Cell Dev Biol. 24:287–297.
2013.
|
|
6
|
Lu J, Wang SL, Wang YC, Wu YN, Yu X, Zhao
WZ and Wang JH: High WAVE3 expression correlates with
proliferation, migration and invasion in human ovarian cancer.
Oncotarget. 8:41189–41201. 2017.
|
|
7
|
Davuluri G, Schiemann WP, Plow EF and
Sossey-Alaoui K: Loss of WAVE3 sensitizes triple-negative breast
cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated
angiogenesis. JAK-STAT. 3:e10092762015. View Article : Google Scholar
|
|
8
|
Moazzam M, Ye L, Sun PH, Kynaston H and
Jiang WG: Knockdown of WAVE3 impairs HGF induced migration and
invasion of prostate cancer cells. Cancer Cell Int. 15:512015.
View Article : Google Scholar
|
|
9
|
Ji Y, Li B, Zhu Z, Guo X, He W, Fan Z and
Zhang W: Overexpression of WAVE3 promotes tumor invasiveness and
confers an unfavorable prognosis in human hepatocellular carcinoma.
Biomed Pharmacother. 69:409–415. 2015. View Article : Google Scholar
|
|
10
|
Yue Z, Feng W, Xiangke L, Liuxing W,
Qingxia F and Jianbo G: WAVE3 promotes epithelial-mesenchymal
transition of gastric cancer through upregulation of Snail. Cancer
Gene Ther. 21:499–506. 2014. View Article : Google Scholar
|
|
11
|
Zhang Y, Guan XY, Dong B, Zhao M, Wu JH,
Tian XY and Hao CY: Expression of MMP-9 and WAVE3 in colorectal
cancer and its relationship to clinicopathological features. J
Cancer Res Clin Oncol. 138:2035–2044. 2012. View Article : Google Scholar
|
|
12
|
Taylor MA, Davuluri G, Parvani JG,
Schiemann BJ, Wendt MK, Plow EF, Schiemann WP and Sossey-Alaoui K:
Upregulated WAVE3 expression is essential for TGF-β-mediated EMT
and metastasis of triple-negative breast cancer cells. Breast
Cancer Res Treat. 142:341–353. 2013. View Article : Google Scholar
|
|
13
|
Sossey-Alaoui K, Ranalli TA, Li X, Bakin
AV and Cowell JK: WAVE3 promotes cell motility and invasion through
the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res.
308:135–145. 2005. View Article : Google Scholar
|
|
14
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar
|
|
15
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar
|
|
16
|
Edge SB; American Joint Committee on
Cancer; ACS: AJCC Cancer Staging Manual. 7th. Springer; New York:
2009
|
|
17
|
Chang B, Li S, He Q, Liu Z, Zhao L, Zhao T
and Wang A: Deregulation of Bmi-1 is associated with enhanced
migration, invasion and poor prognosis in salivary adenoid cystic
carcinoma. Biochim Biophys Acta. 1840.3285–3291. 2014.
|
|
18
|
Deer EL, González-Hernández J, Coursen JD,
Shea JE, Ngatia J, Scaife CL, Firpo MA and Mulvihill SJ: Phenotype
and genotype of pancreatic cancer cell lines. Pancreas. 39:425–435.
2010. View Article : Google Scholar
|
|
19
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar
|
|
20
|
Middleton G, Palmer DH, Greenhalf W,
Ghaneh P, Jackson R, Cox T, Evans A, Shaw VE, Wadsley J and Valle
JW: Vandetanib plus gemcitabine versus placebo plus gemcitabine in
locally advanced or metastatic pancreatic carcinoma (ViP): A
prospective, randomised, double-blind, multicentre phase 2 trial.
Lancet Oncol. 18:486–499. 2017. View Article : Google Scholar
|
|
21
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK and
Vonderheide RH: EMT and dissemination precede pancreatic tumor
formation. Cell. 148:349–361. 2012. View Article : Google Scholar
|
|
22
|
Hao K, Tian XD, Qin CF, Xie XH and Yang
YM: Hedgehog signaling pathway regulates human pancreatic cancer
cell proliferation and metastasis. Oncol Rep. 29:1124–1132. 2013.
View Article : Google Scholar
|
|
23
|
Bo H, Zhang S, Gao L, Chen Y, Zhang J,
Chang X and Zhu M: Upregulation of Wnt5a promotes
epithelial-to-mesenchymal transition and metastasis of pancreatic
cancer cells. BMC Cancer. 13:4962013. View Article : Google Scholar
|
|
24
|
Yang MH, Chen CL, Chau GY, Chiou SH, Su
CW, Chou TY, Peng WL and Wu JC: Comprehensive analysis of the
independent effect of twist and snail in promoting metastasis of
hepatocellular carcinoma. Hepatology. 50:1464–1474. 2009.
View Article : Google Scholar
|
|
25
|
Oda H, Tsukita S and Takeichi M: Dynamic
behavior of the cadherin-based cell-cell adhesion system during
Drosophila gastrulation. Dev Biol. 203:435–450. 1998. View Article : Google Scholar
|
|
26
|
Liu L, Dai Y, Chen J, Zeng T, Li Y, Chen
L, Zhu YH, Li J, Li Y and Ma S: Maelstrom promotes hepatocellular
carcinoma metastasis by inducing epithelial-mesenchymal transition
by way of Akt/GSK-3β/Snail signaling. Hepatology. 59:531–543. 2014.
View Article : Google Scholar
|
|
27
|
Liu A, Shao C, Jin G, Liu R, Hao J, Song
B, Ouyang L and Hu X: miR-208-induced epithelial to mesenchymal
transition of pancreatic cancer cells promotes cell metastasis and
invasion. Cell Biochem Biophys. 69:341–346. 2014. View Article : Google Scholar
|
|
28
|
Yamamoto S, Tomita Y, Hoshida Y, Morooka
T, Nagano H, Dono K, Umeshita K, Sakon M, Ishikawa O and Ohigashi
H: Prognostic significance of activated Akt expression in
pancreatic ductal adenocarcinoma. Clin Cancer Res. 10:2846–2850.
2004. View Article : Google Scholar
|
|
29
|
Stoll V, Calleja V, Vassaux G, Downward J
and Lemoine NR: Dominant negative inhibitors of signalling through
the phos-phoinositol 3-kinase pathway for gene therapy of
pancreatic cancer. Gut. 54:109–116. 2005. View Article : Google Scholar
|
|
30
|
Tang F, Wang Y, Hemmings BA, Rüegg C and
Xue G: PKB/Akt-dependent regulation of inflammation in cancer.
Semin Cancer Biol. 48:62–69. 2018. View Article : Google Scholar
|
|
31
|
Biankin AV, Waddell N, Kassahn KS, Gingras
MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J,
et al Australian Pancreatic Cancer Genome Initiative: Pancreatic
cancer genomes reveal aberrations in axon guidance pathway genes.
Nature. 491:399–405. 2012. View Article : Google Scholar
|
|
32
|
Raphael BJ, Hruban RH, Aguirre AJ, Moffitt
RA, Yeh JJ, Stewart C, Robertson AG, Cherniack AD, Gupta M, Getz G,
et al Cancer Genome Atlas Research Network: Integrated Genomic
Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell.
32:185–203.e13. 2017. View Article : Google Scholar
|
|
33
|
Waddell N, Pajic M, Patch AM, Chang DK,
Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, et al
Australian Pancreatic Cancer Genome Initiative: Whole genomes
redefine the mutational landscape of pancreatic cancer. Nature.
518:495–501. 2015. View Article : Google Scholar
|
